THE FREQUENCY OF HLA-B*57:01 AND THE RISK OF ABACAVIR HYPERSENSITIVITY REACTIONS IN THE COSTA RICA CENTRAL VALLEY POPULATION

被引：0
|
作者：
Arrieta-Bolanos, Esteban [1 ,2 ]
Madrigal, J. Alejandro [3 ,4 ]
Shaw, Bronwen E. [3 ,4 ,5 ]
Marsh, Steven G. E. [3 ,4 ]
Salazar-Sanchez, Lizbeth [2 ]
机构：
[1] Univ Costa Rica, Anthony Nolan Res Inst, UCL Canc Inst, San Jose, Costa Rica
[2] Univ Costa Rica, Ctr Invest Hematol & Trastornos Afines CIHATA, San Jose, Costa Rica
[3] UCL Canc Inst, London, England
[4] Anthony Nolan Res Inst, London, England
[5] Inst Canc Res, Div Mol Pathol, Haematooncol Res Unit, London SW3 6JB, England
来源：
TISSUE ANTIGENS | 2012年 / 79卷 / 06期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：525 / 525
页数：1
相关论文
共 50 条
  • [21] Abacavir adverse reactions related with HLA-B*57:01 haplotype in a large cohort of patients infected with HIV
    Quiros-Roldan, Eugenia
    Gardini, Giulia
    Properzi, Martina
    Ferraresi, Alice
    Carella, Graziella
    Marchi, Alessandro
    Malagoli, Alberto
    Foca, Emanuele
    Castelli, Francesco
    PHARMACOGENETICS AND GENOMICS, 2020, 30 (08): : 167 - 174
  • [22] EXTERNAL QUALITY ASSESSMENT OF HLA-B*57:01 TYPING FOR PROSPECTIVE ABACAVIR PATIENTS
    Corbin, Susan
    Darke, Christopher
    TISSUE ANTIGENS, 2012, 79 (06): : 524 - 525
  • [23] New genetic predictors for abacavir tolerance in HLA-B*57:01 positive individuals
    Pavlos, Rebecca
    Deshpande, Pooja
    Chopra, Abha
    Leary, Shay
    Strautins, Kaija
    Nolan, David
    Thorborn, Daren
    Shaefer, Mark
    Rauch, Andri
    Dunn, David
    Montaner, Julio
    Rachlis, Anita
    Almeida, Coral-Ann
    Choo, Linda
    James, Ian
    Redwood, Alec J.
    Li, Yueran
    Gaudieri, Silvana
    Mallal, Simon A.
    Phillips, Elizabeth J.
    HUMAN IMMUNOLOGY, 2020, 81 (06) : 300 - 304
  • [24] Rapid Near Point-of-Care Assay for HLA-B*57:01 Genotype Associated with Severe Hypersensitivity Reaction to Abacavir
    Wallner, Jackson J.
    Beck, Ingrid A.
    Panpradist, Nuttada
    Ruth, Parker S.
    Valenzuela-Ponce, Humberto
    Soto-Nava, Maribel
    Avila-Rios, Santiago
    Lutz, Barry R.
    Frenkel, Lisa M.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2021, 37 (12) : 930 - 935
  • [25] Abacavir induces loading of novel self-peptides into HLA-B*57:01: an autoimmune model for HLA-associated drug hypersensitivity
    Norcross, Michael A.
    Luo, Shen
    Lu, Li
    Boyne, Michael T.
    Gomarteli, Mary
    Rennels, Aaron D.
    Woodcock, Janet
    Margulies, David H.
    McMurtrey, Curtis
    Vernon, Stephen
    Hildebrand, William H.
    Buchli, Rico
    AIDS, 2012, 26 (11) : F21 - F29
  • [26] HLA-B*57:01 screening and hypersensitivity reaction to abacavir between 1999 and 2016 in the OPERA® observational database: a cohort study
    Karam Mounzer
    Ricky Hsu
    Jennifer S. Fusco
    Laurence Brunet
    Cassidy E. Henegar
    Vani Vannappagari
    Chris M. Stainsby
    Mark S. Shaefer
    Leigh Ragone
    Gregory P. Fusco
    AIDS Research and Therapy, 16
  • [27] HLA-B*57:01 screening and hypersensitivity reaction to abacavir between 1999 and 2016 in the OPERA® observational database: a cohort study
    Mounzer, Karam
    Hsu, Ricky
    Fusco, Jennifer S.
    Brunet, Laurence
    Henegar, Cassidy E.
    Vannappagari, Vani
    Stainsby, Chris M.
    Shaefer, Mark S.
    Ragone, Leigh
    Fusco, Gregory P.
    AIDS RESEARCH AND THERAPY, 2019, 16
  • [28] Comparison of Methods for In-House Screening of HLA-B*57:01 to Prevent Abacavir Hypersensitivity in HIV-1 Care
    De Spiegelaere, Ward
    Philippe, Jan
    Vervisch, Karen
    Verhofstede, Chris
    Malatinkova, Eva
    Kiselinova, Maja
    Trypsteen, Wim
    Bonczkowski, Pawel
    Vogelaers, Dirk
    Callens, Steven
    Ruelle, Jean
    Kabeya, Kabamba
    De Wit, Stephane
    Van Acker, Petra
    Van Sandt, Vicky
    Emonds, Marie-Paule
    Coucke, Paul
    Sermijn, Erica
    Vandekerckhove, Linos
    PLOS ONE, 2015, 10 (04):
  • [29] HLA-B*57:01 allele prevalence in HIV-infected North American subjects and the impact of allele testing on the incidence of abacavir-associated hypersensitivity reaction in HLA-B*57:01-negative subjects
    Catherine Butkus Small
    David A. Margolis
    Mark S. Shaefer
    Lisa L. Ross
    BMC Infectious Diseases, 17
  • [30] HLA-B*57:01 allele prevalence in HIV-infected North American subjects and the impact of allele testing on the incidence of abacavir-associated hypersensitivity reaction in HLA-B*57:01-negative subjects
    Small, Catherine Butkus
    Margolis, David A.
    Shaefer, Mark S.
    Ross, Lisa L.
    BMC INFECTIOUS DISEASES, 2017, 17
12345